Amgen Publishes Asthma Drug Proof-of-Concept in NEJM – Drug Discovery & Development


Drug Discovery & Development

Amgen Publishes Asthma Drug Proof-of-Concept in NEJM
Drug Discovery & Development
Amgen announced that The New England Journal of Medicine (NEJM) published positive results from a Phase 1 study adding to the growing body of evidence that inhibiting thymic stromal lymphopoietin (TSLP) could be beneficial in the treatment of asthma.
Novel Antibody Demonstrates Promise against AsthmaGenetic Engineering News
Amgen drug for allergy asthma shows promise in early testsSFGate
Novel Biologic Promising for Allergic AsthmaMedPage Today
News-Medical.net –Daily Digest
all 31 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.